Unknown

Dataset Information

0

Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations.


ABSTRACT: Many of the gene mutations found in genetic disorders, including cancer, result in premature termination codons (PTC) and the rapid degradation of their mRNAs by nonsense-mediated RNA decay (NMD). We used virtual library screening, targeting a pocket in the SMG7 protein, a key component of the NMD mechanism, to identify compounds that disrupt the SMG7-UPF1 complex and inhibit NMD. Several of these compounds upregulated NMD-targeted mRNAs at nanomolar concentrations, with minimal toxicity in cell-based assays. As expected, pharmacologic NMD inhibition disrupted SMG7-UPF1 interactions. When used in cells with PTC-mutated p53, pharmacologic NMD inhibition combined with a PTC "read-through" drug led to restoration of full-length p53 protein, upregulation of p53 downstream transcripts, and cell death. These studies serve as proof-of-concept that pharmacologic NMD inhibitors can restore mRNA integrity in the presence of PTC and can be used as part of a strategy to restore full-length protein in a variety of genetic diseases.

SUBMITTER: Martin L 

PROVIDER: S-EPMC4040335 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations.

Martin Leenus L   Grigoryan Arsen A   Wang Ding D   Wang Jinhua J   Breda Laura L   Rivella Stefano S   Cardozo Timothy T   Gardner Lawrence B LB  

Cancer research 20140324 11


Many of the gene mutations found in genetic disorders, including cancer, result in premature termination codons (PTC) and the rapid degradation of their mRNAs by nonsense-mediated RNA decay (NMD). We used virtual library screening, targeting a pocket in the SMG7 protein, a key component of the NMD mechanism, to identify compounds that disrupt the SMG7-UPF1 complex and inhibit NMD. Several of these compounds upregulated NMD-targeted mRNAs at nanomolar concentrations, with minimal toxicity in cell  ...[more]

Similar Datasets

| S-EPMC6304956 | biostudies-literature
| S-EPMC6277124 | biostudies-literature
| S-EPMC10769295 | biostudies-literature
| S-EPMC10995974 | biostudies-literature
| S-EPMC5683946 | biostudies-literature
| S-EPMC3648072 | biostudies-literature
| S-EPMC2868547 | biostudies-literature
| S-EPMC5311500 | biostudies-literature
| S-EPMC9525646 | biostudies-literature
| S-EPMC8711849 | biostudies-literature